Ideaya Biosciences Inc (IDYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IDYA | AMGN | VRTX | GILD | BMY |
| Company | Ideaya Biosciences Inc | Amgen Inc | Vertex Pharmaceutic | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 27.13 | 273.81 | 466.52 | 92.46 | 57.03 |
| High | 27.33 | 275.88 | 470.25 | 93.22 | 57.32 |
| Low | 25.44 | 272.15 | 460.05 | 91.44 | 55.94 |
| Last | 25.80 | 274.20 | 464.26 | 92.83 | 56.10 |
| Change | -1.39 | +0.79 | -4.03 | +0.45 | -0.55 |
| % Change | -5.11% | +0.29% | -0.86% | +0.49% | -0.97% |
| Volume | 311,398 | 2,217,582 | 564,176 | 3,199,966 | 8,887,590 |
| 20-Day Average Volume | 1,056,319 | 4,559,002 | 1,308,943 | 6,803,383 | 9,655,515 |
| Previous Close | 27.19 | 273.41 | 468.29 | 92.38 | 56.65 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 26.98 | 281.49 | 463.25 | 91.19 | 58.27 |
| 20-Day Raw Stochastic | 7.14% | 39.76% | 41.24% | 78.88% | 4.69% |
| 20-Day Relative Strength | 39.69% | 34.47% | 48.20% | 56.57% | 48.22% |
| Weighted Alpha | -37.60 | -7.95 | +10.64 | +25.39 | +16.64 |
| Today's Opinion | 100% Sell | 88% Sell | 24% Sell | 100% Buy | 80% Buy |
| Previous Opinion | 100% Sell | 88% Sell | 8% Sell | 100% Buy | 80% Buy |
| Last Month's Opinion | 80% Sell | 40% Sell | 88% Buy | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.00% since 12/05/24 | -0.13% since 12/05/24 | +1.36% since 12/05/24 | -0.59% since 12/05/24 | -4.74% since 12/05/24 |
| Low | 25.56 on 12/12/24 | 270.58 on 12/11/24 | 456.86 on 12/06/24 | 90.50 on 12/09/24 | 55.94 on 12/12/24 |
| High | 28.30 on 12/11/24 | 280.00 on 12/09/24 | 476.46 on 12/10/24 | 94.65 on 12/11/24 | 59.76 on 12/09/24 |
| 1-Month | |||||
| %Chg | -17.43% since 11/12/24 | -8.32% since 11/12/24 | -4.86% since 11/12/24 | -1.60% since 11/12/24 | -5.04% since 11/12/24 |
| Low | 25.20 on 11/21/24 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 86.08 on 11/19/24 | 55.82 on 11/15/24 |
| High | 31.73 on 11/13/24 | 307.43 on 11/13/24 | 498.25 on 11/13/24 | 94.65 on 12/11/24 | 60.68 on 11/25/24 |
| 3-Month | |||||
| %Chg | -29.16% since 09/12/24 | -16.99% since 09/12/24 | -2.61% since 09/12/24 | +11.64% since 09/12/24 | +16.19% since 09/12/24 |
| Low | 25.20 on 11/21/24 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 81.57 on 09/13/24 | 48.20 on 09/13/24 |
| High | 37.80 on 09/16/24 | 339.17 on 09/23/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 |
| 6-Month | |||||
| %Chg | -35.09% since 06/12/24 | -9.00% since 06/12/24 | -2.02% since 06/12/24 | +44.30% since 06/12/24 | +32.16% since 06/12/24 |
| Low | 25.20 on 11/21/24 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 62.69 on 06/18/24 | 39.35 on 07/05/24 |
| High | 44.42 on 07/31/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,350,086 | 146,966,896 | 120,598,248 | 115,130,048 | 114,896,232 |
| Shares Outstanding, K | 86,432 | 537,533 | 257,529 | 1,246,266 | 2,028,177 |
| Annual Sales | 23,390,000 | 28,190,000,000 | 9,869,200,000 | 27,116,000,000 | 45,006,000,000 |
| Annual Net Income | -112,960,000 | 6,717,000,000 | 3,619,600,000 | 5,665,000,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 8,503,000,000 | 2,771,900,000 | 7,545,000,000 | 11,892,000,000 |
| Last Quarter Net Income | -51,820,000 | 2,830,000,000 | 1,045,400,000 | 1,253,000,000 | 1,211,000,000 |
| 60-Month Beta | 0.79 | 0.55 | 0.36 | 0.18 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.60 on 11/04/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 | 1.80 on 10/31/24 |
| Latest Earnings Date | 11/05/24 | 02/04/25 | 02/03/25 | 02/04/25 | 10/31/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | 0.770 on 12/13/24 | 0.600 on 10/04/24 |
| Next Ex-Dividends Date | N/A | 02/14/25 | N/A | 12/13/24 | 10/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.35 | 0.00 | 20.84 | 49.68 |